NCT02257008View on ClinicalTrials.gov

Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

December 31, 2003

Conditions
Healthy
Interventions
DRUG

BILR 355 BS

OTHER

Grapefruit juice

DRUG

Nelfinavir

DRUG

Atazanavir

DRUG

Ritonavir

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY